The Brazilian Senate recently approved significant legislative reforms, setting the stage for a considerable advancement in pharmaceutical clinical research.
These regulations aim to attract investments totaling 5 billion reais (approximately $1 billion). Consequently, Brazil anticipates a new era of medical innovation.
The bill, which reinforces the National System of Ethics in Clinical Research with Human Beings, now awaits the president's signature to become law.
This legislative action promises to elevate Brazil's status in global medical science, positioning it as a leader in groundbreaking research.
The country will see improvements from the initial stages of molecule testing to the. . .
To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed? Login Here